# Evidence Lacking for Mental Health Monitoring Tech
A panel investigating mental health technology heard testimony this week suggesting that artificial intelligence tools designed to monitor patient wellbeing lack solid scientific backing. The Lampard Inquiry, examining mental health apps and monitoring systems, examined Oxevision technology during recent hearings.
Oxevision uses cameras and AI to track patient behavior, posture, and movement in clinical settings, with developers claiming it can detect deterioration in mental health conditions. The technology has been deployed in some UK hospitals as a tool for observing patients with serious mental illness.
Experts testifying before the inquiry raised concerns about the research foundation supporting such systems. While the company behind Oxevision argues the technology provides objective data about patient status, independent researchers questioned whether published studies adequately demonstrate clinical effectiveness or safety.
The inquiry heard that mental health monitoring technology often advances faster than rigorous validation processes can move. Developers release tools into clinical practice based on preliminary data, leaving hospitals to make decisions about patient care without complete evidence of benefit or risk.
This pattern reflects a broader problem in digital mental health. Many apps and systems marketed to clinicians rely on limited trial data or lack peer-reviewed research entirely. The mental health sector has embraced monitoring technology in hopes of improving care and identifying crisis situations early, but implementation often outpaces evidence gathering.
The Lampard Inquiry's focus on this gap matters for patients. When hospitals adopt unproven technology for monitoring vulnerable people, they make clinical decisions based on incomplete information. Staff may misinterpret algorithmic alerts or rely on automated assessments that haven't been properly tested in diverse patient populations.
The hearing suggests the UK mental health system needs stronger protocols before deploying monitoring technology. This includes requiring adequate clinical trials before hospital adoption and continuing evaluation after implementation. The inquiry's findings may reshape how the NHS assesses and approves digital mental health tools going forward.